Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ILOPROST vs IMATINIB: Safety Overview

Metric ILOPROST IMATINIB
Total FAERS Reports 4,961 43,161
Deaths Reported 2,277 13,761
Death Rate 45.9% 31.9%
Hospitalizations 2,324 7,264
Average Patient Age 57.9 yrs 55.7 yrs
% Female Patients 70.7% 47.2%
FDA Approval Date Aug 7, 2009 Apr 14, 2025
Manufacturer BTG International Inc Dr.Reddy's Laboratories Inc
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued